Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins

Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins BACKGROUND: Human parvovirus B19 (B19V) is a highly prevalent pathogen, and plasma pools for manufacturing of plasma‐derived products have been shown to contain antibodies against B19V (B19V immunoglobulin G (IgG)). STUDY DESIGN AND METHODS: The megakaryoblastic cell line UT7/Epo‐S1 can be infected with B19V Genotype 1 and as demonstrated here by immunocytochemistry, Western blot, and reverse transcription–polymerase chain reaction (RT‐PCR) of B19V‐specific mRNA, also with the more recently discovered Genotype 2. Based on B19V RT‐PCR analysis of infected UT7/Epo‐S1 cells, an infectivity assay was established and implemented for a B19V neutralization assay. To investigate the role of B19V neutralization in relation to B19V IgG titers, more than 1000 manufacturing plasma pools were tested by enzyme‐linked immunosorbent assay. RESULTS: Plasma pools were found to contain a mean B19V IgG titer of 33 ± 9 IU per mL, with the lowest titer at 11 IU per mL. These 11 IU per mL B19V IgG neutralized 4.6 log B19V Genotype 1 and greater than 3.9 log Genotype 2 infectivity. Accordingly, a 10 percent intravenous immunoglobulin (IVIG) product prepared from such pools was found to contain an even higher B19V neutralization capacity. CONCLUSION: A high capacity of B19V Genotypes 1 and 2 neutralization was demonstrated in plasma pools for fractionation, an inherent feature based on the constantly high titer of B19V IgG in these pools. The neutralizing activity of B19V IgG was shown to be maintained in the 10 percent IVIG product tested. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Transfusion Wiley

Neutralization of human parvovirus B19 by plasma and intravenous immunoglobulins

Loading next page...
 
/lp/wiley/neutralization-of-human-parvovirus-b19-by-plasma-and-intravenous-N23xSKEHGm
Publisher site
See Article on Publisher Site

Abstract

BACKGROUND: Human parvovirus B19 (B19V) is a highly prevalent pathogen, and plasma pools for manufacturing of plasma‐derived products have been shown to contain antibodies against B19V (B19V immunoglobulin G (IgG)). STUDY DESIGN AND METHODS: The megakaryoblastic cell line UT7/Epo‐S1 can be infected with B19V Genotype 1 and as demonstrated here by immunocytochemistry, Western blot, and reverse transcription–polymerase chain reaction (RT‐PCR) of B19V‐specific mRNA, also with the more recently discovered Genotype 2. Based on B19V RT‐PCR analysis of infected UT7/Epo‐S1 cells, an infectivity assay was established and implemented for a B19V neutralization assay. To investigate the role of B19V neutralization in relation to B19V IgG titers, more than 1000 manufacturing plasma pools were tested by enzyme‐linked immunosorbent assay. RESULTS: Plasma pools were found to contain a mean B19V IgG titer of 33 ± 9 IU per mL, with the lowest titer at 11 IU per mL. These 11 IU per mL B19V IgG neutralized 4.6 log B19V Genotype 1 and greater than 3.9 log Genotype 2 infectivity. Accordingly, a 10 percent intravenous immunoglobulin (IVIG) product prepared from such pools was found to contain an even higher B19V neutralization capacity. CONCLUSION: A high capacity of B19V Genotypes 1 and 2 neutralization was demonstrated in plasma pools for fractionation, an inherent feature based on the constantly high titer of B19V IgG in these pools. The neutralizing activity of B19V IgG was shown to be maintained in the 10 percent IVIG product tested.

Journal

TransfusionWiley

Published: Jan 1, 2008

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off